Evidence map›Paper›PMID 22143764›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2011

The genomic binding sites of a noncoding RNA.

Matthew D Simon, Charlotte I Wang, Peter V Kharchenko, Jason A West, Brad A Chapman, Artyom A Alekseyenko, Mark L Borowsky, Mitzi I Kuroda, Robert E Kingston

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 275 papers.

0numbers the graph read from it
0cells of the map it votes in
275citing papers in PubMed
10.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

275 citing papers in PubMed, 459 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Microfluidic low-input profiling reveals lncRNA roles in disease.bioRxiv : the preprint server for biology · 2026
    Article
  8. Review
  9. Protein-Centric Mapping of RNA-DNA Interactions with RedChIP.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article

215 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Matthew D SimonDepartment of Molecular Biology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
Charlotte I Wang
Peter V Kharchenko
Jason A West
Brad A Chapman
Artyom A Alekseyenko
Mark L Borowsky
Mitzi I Kuroda
Robert E Kingston
Harvard University · USBrigham and Women's Hospital · USBoston Children's Hospital · US

Funding

Maintenance of Gene ExpressionR01GM043901 · NIGMS · MASSACHUSETTS GENERAL HOSPITAL · PI KINGSTON, ROBERT · 1991 to 2018
$10.7M
Transcription Factor Interactions with NucleosomesR37GM048405 · NIGMS · MASSACHUSETTS GENERAL HOSPITAL · PI KINGSTON, ROBERT · 2009 to 2018
$3.9M
Molecular Genetics of Dosage Compensation in DrosophilaR37GM045744 · NIGMS · BRIGHAM AND WOMEN'S HOSPITAL · PI KURODA, MITZI I · 2004 to 2013
$3.7M
MOLECULAR GENETICS OF DOSAGE COMPENSATION IN DROSOPHILAR01GM045744 · NIGMS · BRIGHAM AND WOMEN'S HOSPITAL · PI KURODA, MITZI I · 1991 to 2017
$2.3M
NIGMS NIH HHS 5R01GM043901NIGMS NIH HHS GM045744NIGMS NIH HHS R01 GM043901NIGMS NIH HHS R01 GM045744NIGMS NIH HHS R37 GM045744NIGMS NIH HHS R37 GM048405
6 · The paper itself

Abstract

Long noncoding RNAs (lncRNAs) have important regulatory roles and can function at the level of chromatin. To determine where lncRNAs bind to chromatin, we developed capture hybridization analysis of RNA targets (CHART), a hybridization-based technique that specifically enriches endogenous RNAs along with their targets from reversibly cross-linked chromatin extracts. CHART was used to enrich the DNA and protein targets of endogenous lncRNAs from flies and humans. This analysis was extended to genome-wide mapping of roX2, a well-studied ncRNA involved in dosage compensation in Drosophila. CHART revealed that roX2 binds at specific genomic sites that coincide with the binding sites of proteins from the male-specific lethal complex that affects dosage compensation. These results reveal the genomic targets of roX2 and demonstrate how CHART can be used to study RNAs in a manner analogous to chromatin immunoprecipitation for proteins.

Indexed as

GenomicsAmino Acid MotifsAnimalsBinding SitesChromatinChromatin ImmunoprecipitationDosage Compensation, GeneticDrosophilaDrosophila ProteinsMaleModels, GeneticNucleic Acid HybridizationRibonuclease HRNA-Binding ProteinsRNA, UntranslatedChromatinDrosophila ProteinsPabp2 protein, DrosophilaRibonuclease HRNA-Binding ProteinsRNA, Untranslated

Identifiers

PMID22143764
PMCPMC3251105
OpenAlexW1992212213

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.